Insider Buying: FGL Holdings (FG) Director Purchases 50,000 Shares of Stock

Share on StockTwits

FGL Holdings (NYSE:FG) Director Richard N. Massey bought 50,000 shares of the company’s stock in a transaction on Wednesday, September 12th. The stock was bought at an average cost of $8.76 per share, for a total transaction of $438,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

NYSE:FG opened at $8.69 on Friday. FGL Holdings has a 1 year low of $8.14 and a 1 year high of $11.94. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.40.

FGL (NYSE:FG) last released its quarterly earnings results on Thursday, August 9th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.01. The business had revenue of $340.00 million during the quarter, compared to the consensus estimate of $330.53 million. During the same period in the previous year, the company posted $0.72 EPS. The company’s revenue for the quarter was down 10.5% compared to the same quarter last year. equities analysts predict that FGL Holdings will post 1.13 EPS for the current fiscal year.

Several large investors have recently added to or reduced their stakes in FG. Trexquant Investment LP bought a new position in shares of FGL in the first quarter worth $503,000. Quantitative Systematic Strategies LLC bought a new position in FGL during the first quarter valued at about $180,000. Schwab Charles Investment Management Inc. bought a new position in FGL during the first quarter valued at about $4,293,000. Northern Trust Corp bought a new position in FGL during the first quarter valued at about $2,721,000. Finally, BlackRock Inc. boosted its stake in FGL by 347.4% during the first quarter. BlackRock Inc. now owns 3,111,538 shares of the company’s stock valued at $31,582,000 after buying an additional 2,415,996 shares in the last quarter. 72.44% of the stock is owned by institutional investors.

Several equities research analysts have weighed in on FG shares. Zacks Investment Research raised FGL from a “hold” rating to a “buy” rating and set a $9.75 target price on the stock in a research report on Monday, September 3rd. ValuEngine raised FGL from a “sell” rating to a “hold” rating in a research note on Friday, August 17th. Goldman Sachs Group assumed coverage on FGL in a research note on Tuesday, August 21st. They issued a “neutral” rating and a $10.50 price target for the company. Credit Suisse Group decreased their price target on FGL from $11.00 to $10.00 and set a “neutral” rating for the company in a research note on Friday, August 17th. Finally, Royal Bank of Canada assumed coverage on FGL in a research note on Tuesday, July 17th. They issued an “outperform” rating and a $10.00 price target for the company. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $10.45.

About FGL

FGL Holdings, through its subsidiaries, sells individual life insurance products and annuities in the United States. The company offers deferred annuities, including fixed indexed annuity contracts and fixed rate annuity contracts; immediate annuities; and life insurance products. It also provides life and annuity reinsurance services, such as reinsurance on asset intensive, long duration life, and annuity liabilities.

Recommended Story: Growth Stocks, What They Are, What They Are Not

Receive News & Ratings for FGL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FGL and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Audentes Therapeutics Inc  Forecasted to Earn FY2018 Earnings of  Per Share
Audentes Therapeutics Inc Forecasted to Earn FY2018 Earnings of Per Share
Veeco Instruments  Stock Rating Lowered by ValuEngine
Veeco Instruments Stock Rating Lowered by ValuEngine
Peel Hunt Reaffirms “Buy” Rating for Eland Oil & Gas
Peel Hunt Reaffirms “Buy” Rating for Eland Oil & Gas
GlaxoSmithKline  Stock Rating Reaffirmed by Credit Suisse Group
GlaxoSmithKline Stock Rating Reaffirmed by Credit Suisse Group
Bottomline Technologies  Upgraded by First Analysis to “Strong-Buy”
Bottomline Technologies Upgraded by First Analysis to “Strong-Buy”
Almost Never Films  and Zumiez  Head to Head Survey
Almost Never Films and Zumiez Head to Head Survey


© 2006-2018 Ticker Report